Tarsons Products Limited

Tarsons Products Limited (TARSONS) is a micro-cap Healthcare company valued at ₹1,760 crore operating in Medical Equipment & Supplies on the NSE and BSE.

Recent price move

Tarsons Products Limited last traded at ₹330.25, modestly up 1.04% on the day.

Recent developments

On 2026-06-30, the company reported a net profit loss of ₹1 crore for the latest quarter, compared to a net profit of ₹2 crore in the same quarter a year earlier. Promoter holding remained at 47.30% as of 2026-06-30, while foreign institutional holding decreased by 0.71 percentage points to 0.16% and domestic institutional holding decreased by 0.09 percentage points to 0.10%.

Financial performance

Annual revenue rose 7.8% to ₹423 crore, but annual net profit fell 52.3% to ₹14 crore. The latest quarter saw revenue increase 20.7% year-on-year to ₹110 crore, while net profit swung to a loss of ₹1 crore from a profit of ₹2 crore in the same quarter a year earlier. The net profit margin dropped 4.3 percentage points to 3.4%, and return on equity was 0.0%.

Valuation multiples

The stock trades at 41.2 times earnings, a premium to the Healthcare median of 32.0, 2.67 times book value. It yields 0.6%.

Things to watch

The latest quarter ended with a net profit loss of ₹1 crore, compared to a net profit of ₹2 crore in the same quarter a year earlier. The net profit margin fell 4.3 percentage points to 3.4%. The company's return on equity was 0.0%, and the stock is 12.2% below its 52-week high.

Where it stands

The company's annual revenue grew 7.8% to ₹423 crore, but annual net profit fell 52.3% to ₹14 crore. The latest quarter saw a net profit loss of ₹1 crore, compared to a net profit of ₹2 crore in the same quarter a year earlier. The stock is 12.2% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.